Beyondspring Inc. shares surge 15.39% intraday after selling part of its SEED Therapeutics Inc. preferred stock for $35.42 million.

Beyondspring Inc. surged 15.39% intraday, following the announcement that Wanchun Pharmaceuticals has agreed to sell part of its preferred shares in SEED Therapeutics Inc. to three investors by January 2025, expecting to gain approximately $35,418,000 in revenue. Additionally, Wanchun Pharmaceuticals' stock has risen 50.29% in the past five days and has accumulated a 56.75% increase year-to-date.